IN2014KO00191A - - Google Patents

Download PDF

Info

Publication number
IN2014KO00191A
IN2014KO00191A IN191KO2014A IN2014KO00191A IN 2014KO00191 A IN2014KO00191 A IN 2014KO00191A IN 191KO2014 A IN191KO2014 A IN 191KO2014A IN 2014KO00191 A IN2014KO00191 A IN 2014KO00191A
Authority
IN
India
Prior art keywords
compounds
general formula
present
compositions
derivatives
Prior art date
Application number
Other languages
English (en)
Inventor
Nayan Sinha Barij
Kumar Timiri Ajay
Jayaprakash Venkatesan
Original Assignee
Barij Nayan Sinha Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barij Nayan Sinha Dr filed Critical Barij Nayan Sinha Dr
Priority to IN191KO2014 priority Critical patent/IN2014KO00191A/en
Publication of IN2014KO00191A publication Critical patent/IN2014KO00191A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN191KO2014 2014-02-17 2014-02-17 IN2014KO00191A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN191KO2014 IN2014KO00191A (es) 2014-02-17 2014-02-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN191KO2014 IN2014KO00191A (es) 2014-02-17 2014-02-17

Publications (1)

Publication Number Publication Date
IN2014KO00191A true IN2014KO00191A (es) 2015-08-21

Family

ID=54393489

Family Applications (1)

Application Number Title Priority Date Filing Date
IN191KO2014 IN2014KO00191A (es) 2014-02-17 2014-02-17

Country Status (1)

Country Link
IN (1) IN2014KO00191A (es)

Similar Documents

Publication Publication Date Title
PH12016501440A1 (en) Novel heterocyclic compounds
PH12018500610A1 (en) Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity
MY192521A (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
MX2018002402A (es) Compuestos de heteroarilo o arilo biciclicos fusionados como moduladores de la quinasa 4 asociada al receptor de la interleucina 1 (irak4).
MY189761A (en) Quinazoline derivatives used to treat hiv
MD4800C1 (ro) Compuşi de aminopirimidinil ca inhibitori de JAK
PH12016501355B1 (en) Bicyclic heterocyclic derivatives as bromodomain inhibitors
TN2017000511A1 (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them.
MX2017008520A (es) Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2016011632A (es) Derivados de azaspiro como antagonistas de trpm8.
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
MY194116A (en) Pharmaceutical compounds
UA118120C2 (uk) Макроциклічні похідні піридину
NZ725399A (en) Macrocylic pyrimidine derivatives
PH12016500885A1 (en) Novel heterocyclic compounds
TW201613864A (en) Novel compounds
MX2017009292A (es) Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3.
TR201819805T4 (tr) Flavaglin türevleri̇.
MY193041A (en) Novel fused imidazobenzothiazole compounds
TN2017000342A1 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
MX2016014143A (es) Derivados de diheterociclo enlazado a cicloalquilo.
PH12016501625A1 (en) Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
MX2017002544A (es) Derivados de isoquinolinona utiles en el tratamiento contra el cancer.
NZ748942A (en) Pyrazolylaminobenzimidazole derivatives as jak inhibitors
PH12017500323B1 (en) P38 map kinase inhibiting indanyl urea compounds